# K220407: Visby Medical Sexual Health Test

- Pathway: 510(k) (Dual Track)
- Applicant: Visby Medical
- Decided: Mar 7, 2023 after 386 days
- Product code: QEP (Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections)
- Device class: 2
- Regulation: 21 CFR 866.3393
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to P950039 (1996). 10 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K200748: Visby Medical Sexual Health, Visby Medical (2021) Summary page 4.

## Most influential descendants
- K251501: Visby Medical Men's Sexual Health Test (2025), 0 descendants of its own

## Indications for use
The Visby Medical Sexual Health Test is a single-use (disposable), fully-integrated, automated Polymerase Chain Reaction (PCR) in vitro diagnostic test intended for use in point-of-care or clinical laboratory settings for the rapid detection and differentiation of DNA from Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in self-collected female vaginal swab specimens using the Visby Medical Sexual Health Vaginal Specimen Collection Kit in a health care setting. The test results are to aid in the diagnosis of symptomatic or asymptomatic infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.

Source page: https://510kreport.com/device/K220407
Methodology: https://510kreport.com/methodology